You are not connected. The newsletter may include some user information, so they may not be displayed correctly.

ASCIA Update 10 January 2023

ASCIA Update 10 January 2023
This email contains pictures, if you don’t see them, view it online
 
ASCIA Update aims to provide current information to the community about allergic diseases, immunodeficiencies and other immune diseases.
 

10 January 2023

ASCIA meetings in 2023 

ASCIA meetings in 2023

On behalf of the ASCIA team, best wishes for the new year.

We look forward to seeing you at ASCIA meetings this year, including the ASCIA 2023 Conference in September, and other meetings in March and May 2023, which are listed on the ASCIA Conference Meetings and Events Calendar

   
Meat

New ASCIA tick and mammalian meat allergy FAQ

A new FAQ about tick and mammalian meat allergy has been developed by ASCIA.

Clinical immunology/allergy specialists in Australia were the first to describe a link between tick bites and the development of mammalian meat allergy (MMA). In people with MMA, an allergic reaction can be caused by eating meat from mammals, meat products and animal-derived gelatin, which can be in food products and medications.

   
Updated ASCIA adrenaline injectors FAQ and other resources 

Updated ASCIA adrenaline injectors FAQ and other resources

ASCIA adrenaline injectors FAQ has been updated in 2023 to provide more clarity about using different doses and brands.

This FAQ is one of 11 ASCIA resources that have also been updated to include the Pharmac funding of EpiPen adrenaline injectors from  February 2023. This will benefit thousands of New Zealanders with severe allergies who are at risk of anaphylaxis. Read more here

   
New primary immunodeficiency animation videos 

New primary immunodeficiency animation videos

Links to new animation videos about primary immunodeficiencies are now on the ASCIA website

These videos have been developed by the International Patient Organisation for Primary Immunodeficiencies (IPOPI), to increase the understanding of these conditions, the importance of early detection and access to treatments. 

   
PBAC feedback due by 25 January 2023 

PBAC feedback due by 25 January 2023

The March 2023 meeting of the Pharmaceutical Benefits Advisory Committee (PBAC) includes three products that are relevant to ASCIA members - Jorveza¬ģ for EoE, EleCare¬ģ LCP for CMA and Saphnelo¬ģ for SLE. Feedback is due by 25 January 2023.

Read more here

   
How is ASCIA website information developed and updated? 

How is ASCIA website information developed and updated?

There are more than 400 accessible, consistent and evidence-based resources on the ASCIA website, which are regularly developed, reviewed and updated. Updates are made in response to requests, recommendations, changes in clinical and academic expert consensus, changes in the published literature and product updates.

Read more here 

   
Recent ASCIA website updates 

Recent ASCIA website updates

Animation videos on ASCIA website

Voluntary recall of ALK peanut SPT batches

Allergic reactions to dental products containing Recaldent

ASCIA dietary guides updated with ReadSpeaker

New ASCIA HAE e-training for health professionals

Updated ASCIA HAE position paper

Updated ASCIA anaphylaxis e-training and action plans

New ASCIA anaphylaxis translations webpage

   
Current and future priorities for ASCIA 

Current and future priorities for ASCIA

ASCIA priorities for 2022-2023 are listed on the ASCIA website 

Thank you to all ASCIA members in Australia and New Zealand who completed a short survey, which will help to determine the most important current and future priorities for ASCIA. The survey is still open until the end of January and a report will be available by March.

   
ASCIA webpages are regularly updated:  

ASCIA webpages listed below are regularly updated

ASCIA Submissions

ASCIA Collaborations

Publications

Research Studies

Locate a Specialist

Allergy/Immunology Positions

Conference, Meetings and Events Calendar

A gratefully acknowledges the generous support of all sponsors listed on the ASCIA website www.allergy.org.au/about-ascia/sponsors

 
 
  ASCIA is the peak professional body of clinical immunology and allergy in
Australia and New Zealand
- - -
ASCIA Updates provide current information to the community about
allergic diseases, primary immunodeficiencies and other immune diseases.
 
 
 
ASCIAThe purpose of ASCIA is to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with allergic diseases, immunodeficiencies and other immune diseases.
 
 
 
AIFAAIFA is dedicated to improving the health of people with allergy and other immune diseases by funding medical research and raising awareness. 
Donate here…
 
     
ASCIA 2023 Conference 600 emd
 
Linkedintwitter facebookwww.allergy.org.au | contact us
Prefer not to receive our news anymore unsubscribe.

---